九城關貿 NINE 深 滬
等待開盤 04-01 09:30:00 美东时间
8.20
-1.600
-16.33%
華盛通- 最 高10.50
- 今 開9.80
- 成交量 8.32万股
- 最 低 7.32
- 昨 收 9.80
- 總市值 3.56亿
- 52周最高 10.50
- 市盈率 靜 --
- 換手率 0.19%
- 52周最低 0.00
- 委 比 0.00%
- 總股本 4336.13万
- 歷史最高 10.50
- 量 比 0
- 振 幅 32.45%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Taylor Devices Announces Third Quarter And Nine-Month Results Including Record High Nine-Month Sales
BRIEF-Taylor Devices Announces Third Quarter And Nine-Month Results Including Record High Nine-Month Sales March 31 (Reuters) - Taylor Devices Inc TAYD.O : TAYLOR DEVICES ANNOUNCES THIRD QUARTER AND NINE-MONTH RESULTS INCLUDING RECORD HIGH NINE-MONTH SALES TAYLOR DEVICES INC - Q3 SALES $11.2 MILLION
03-31 20:42
BRIEF-Nine Energy Service Approved For Listing On NYSE American
BRIEF-Nine Energy Service Approved For Listing On NYSE American NINE ENERGY SERVICE APPROVED FOR LISTING ON NYSE AMERICAN NINE ENERGY: ANTICIPATES ITS COMMON STOCK WILL BEGIN TRADING ON NYSE AMERICAN MARCH 31, 2026, AT MARKET OPEN, UNDER TICKER SYMBOL "NINE" Source text: ID:nBw4tXpVda Further compan
03-26 20:50
UPDATE 10-Air Canada jet collision shuts LaGuardia; pilots killed, dozens injured
UPDATE 10-Air Canada jet collision shuts LaGuardia; pilots killed, dozens injured Both pilots killed, 41 injured, some seriously Fire truck was responding to a separate United Airlines flight LaGuardia airport closed until 2 p.m. ET on Monday, FAA says Photos after accident show damage to the plane'
03-23 12:45
BRIEF-Alar Pharmaceuticals Inc - Announces Positive Results For Ala-1000 In Canine Osteoarthritis Study
BRIEF-Alar Pharmaceuticals Inc - Announces Positive Results For Ala-1000 In Canine Osteoarthritis Study March 16 (Reuters) - Alar Pharmaceuticals Inc 6785.TWO : ALAR PHARMACEUTICALS INC - ANNOUNCES POSITIVE RESULTS FOR ALA-1000 IN CANINE OSTEOARTHRITIS STUDY ALAR PHARMACEUTICALS INC - ALA-1000 SHOWS
03-16 20:17
BRIEF-Sanofi And Regeneron’S Dupixent Approved In The U.S. For Allergic Fungal Rhinosinusitis
BRIEF-Sanofi And Regeneron’S Dupixent Approved In The U.S. For Allergic Fungal Rhinosinusitis Feb 24 (Reuters) - Sanofi SA SASY.PA : SANOFI AND REGENERON’S DUPIXENT APPROVED IN THE US AS THE FIRST AND ONLY MEDICINE FOR ALLERGIC FUNGAL RHINOSINUSITIS PHASE 3 STUDY SHOWS DUPIXENT REDUCES NASAL SIGNS A
02-24 22:33
BRIEF-Expand Energy Says Winter Storm Fern Reduced Haynesville Output
BRIEF-Expand Energy Says Winter Storm Fern Reduced Haynesville Output Feb 18 (Reuters) - Expand Energy Corp EXE.O : EXPAND ENERGY SAYS HAYNESVILLE BREAKEVENS HAVE FALLEN 15% - CONF CALL EXPAND ENERGY SAYS CEO SEARCH MAY TAKE SIX TO NINE MONTHS - CONF CALL EXPAND ENERGY SAYS ROUGHLY HALF OF NEW DEMAN
02-18 22:49
BRIEF-Mobil Oil Australia Says Co & Australia's ACCC Agreed Settlement Regarding Mobil ‘Synergy’ Branding
BRIEF-Mobil Oil Australia Says Co & Australia's ACCC Agreed Settlement Regarding Mobil ‘Synergy’ Branding Feb 17 (Reuters) - Mobil Oil Australia: CO AND ACCC AGREED TO SETTLEMENT REGARDING MOBIL ‘SYNERGY’ BRANDING AT NINE SERVICE STATIONS IN QUEENSLAND UNDERTAKEN STEPS TO EITHER NOT INSTALL SPECIFIC
02-17 10:41
BRIEF-Australia's ACCC Says Mobil To Pay A$16 Million In Penalties For Misleading Statements About Fuel Sold
BRIEF-Australia's ACCC Says Mobil To Pay A$16 Million In Penalties For Misleading Statements About Fuel Sold Feb 17 (Reuters) - Australian Competition and Consumer Commission: MOBIL TO PAY A$16M IN PENALTIES FOR MISLEADING STATEMENTS ABOUT FUEL SOLD AT NINE PETROL STATIONS FEDERAL COURT ORDERED MOBI
02-17 10:05
BRIEF-Loyal Raises $100M Series C, Led By Age1, To Advance First Canine Longevity Drug
BRIEF-Loyal Raises $100M Series C, Led By Age1, To Advance First Canine Longevity Drug Feb 11 (Reuters) - LOYAL RAISES $100M SERIES C, LED BY AGE1, TO ADVANCE FIRST CANINE LONGEVITY DRUG Source text: ID:nBwbLpVgta Further company coverage: [ ] (( Reuters.Briefs@thomsonreuters.com ;))
02-11 22:55
BRIEF-IceCure Announces Planned Departure of CFO
BRIEF-IceCure Announces Planned Departure of CFO Feb 9 (Reuters) - Icecure Medical Ltd ICCM.O : ICECURE ANNOUNCES PLANNED DEPARTURE OF CFO FOLLOWING NINE YEARS OF SERVICE AND KEY MILESTONES ACHIEVED ICECURE MEDICAL LTD - ANNOUNCES DEPARTURE OF CFO RONEN TSIMERMAN ICECURE MEDICAL LTD - RONEN TSIMERMA
02-10 06:12
